Navigation Links
Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Pall's Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
Date:8/1/2012

BRAINTREE, Mass., Aug. 1, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported first quarter 2013 GAAP net revenue of $176.5 million, up 3%, net income of $9.8 million, down 42%, and diluted earnings per share of $0.38 down 42%.  Excluding restructuring, transformation and transaction costs, adjusted first quarter net income was $14.3 million, down 16%, and adjusted earnings per share were $0.55, down 15%.  Excluding currency impacts, net revenue was up 3% in the quarter.(1)

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )

Brian Concannon, Haemonetics' President and CEO, commented: "We're especially encouraged with 11% growth in our hospital business on strength in surgical and diagnostics disposables across all markets. Demand for the Cell Saver® Elite®, our newest cell salvage device, and TEG® disposables continued to show strength, as more hospital customers embrace the value of our Blood Management Solutions.
Excluding the impact in the quarter of the Japanese Red Cross ("JRC") "buy in" in the previous quarter, our revenue grew 6% in total."STRATEGIC AND PRODUCT GROWTH HIGHLIGHTSHaemonetics continues to make progress expanding its business, reporting the following highlights:

  • Completed the acquisition of Transfusion Medicine Business from Pall Corporation.
  • New share repurchase of up to $50 million authorized.
  • 20% growth in equipment sales, giving confidence that disposables revenue growth will continue.
  • Sold or placed a record 172 TEG diagnostic devices and 229 Cell Saver Elite devices.
  • 16% revenue growth in diagnostic disposables products, on the strength of 70% growth in China.
  • 16% growth in surgical disposables, with Blood Management Solu
    '/>"/>

  • SOURCE Haemonetics Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    2. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    3. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    5. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    6. Pharmasset Reports Fiscal Year End 2011 Financial Results
    7. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
    8. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
    9. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
    10. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
    11. Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... Madison, WI (PRWEB) January 22, 2015 Dr. ... at the 12th annual Scripps Natural Supplements Pre-Conference seminar on ... Supplements Conference is an annual continuing education conference for health ... 15th and included the topic of probiotics in health. Dr. ...
    (Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
    (Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
    (Date:12/24/2014)... GMO corn cases filed across the United States, and ... being consolidated in a Kansas federal court for pretrial proceedings. ... Corn Litigation, MDL No. 2591 in the U.S. District Court ... GMO corn multidistrict litigation (MDL) has been handed over to ...
    Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
    ... Abstract , ... that produce highpurity total RNA from biological sources such as cultured ... other manual handling, and produce a highly pure product, free of ... These new techniques respond to the demand ...
    ... Overview , ... biomarkers increases in importance, extensive lists of candidate markers are being ... larger numbers of candidate genomic markers exist from DNA transcriptional profiling ... While these genomic markers can ...
    ... Wild-type T4 Polynucleotide Kinase (PNK) ... 5'-ends of DNA and oligonucleotides. Labeling, in particular, can be ... reaction (Fig. 1) (3) . Historically, T4 PNK has played ... be important in applications such as labeling of probes for ...
    Cached Biology Technology:Total RNA Purification from Cultured Cells Using the ABI PRISM 6700 Automated Nucleic Acid Workstation and Total RNA Lysis Reagents 2Total RNA Purification from Cultured Cells Using the ABI PRISM 6700 Automated Nucleic Acid Workstation and Total RNA Lysis Reagents 3Total RNA Purification from Cultured Cells Using the ABI PRISM 6700 Automated Nucleic Acid Workstation and Total RNA Lysis Reagents 4Total RNA Purification from Cultured Cells Using the ABI PRISM 6700 Automated Nucleic Acid Workstation and Total RNA Lysis Reagents 5Total RNA Purification from Cultured Cells Using the ABI PRISM 6700 Automated Nucleic Acid Workstation and Total RNA Lysis Reagents 6Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 2Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 3Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 4Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 5 USB OptiKinase Eliminates Base Bias in Labeling of Oligonucleotide 5'-Ends 2 USB OptiKinase Eliminates Base Bias in Labeling of Oligonucleotide 5'-Ends 3
    (Date:12/19/2014)... Inc., the leading personal genetics company, today announced the publication ... of individuals from across the United States ... hundred years ago, the United States ... continents. This study illuminates how American history and the ongoing ...
    (Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM announced ... audit to confirm its adherence to current U.S. Food ... to conduct regulated smart device and smart phone application ... research quality. "HITLAB is determined to improve ...
    (Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a technology ... measures the overall facial feature of a person such ...
    Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
    ... that is a primary target of the degenerative brain ... as Alzheimer's disease in patients who develop dementia before ... recently in evolutionary history -- in a common ancestor ... in humans, and the finding supports the concept that ...
    ... researchers at the University of Illinois at Urbana-Champaign have ... of social behavior in humans. , "The honey bee ... social behavior," said Saurabh (pronounced SAW-rub) Sinha, a professor ... Institute for Genomic Biology. Using that model system, Sinha ...
    ... general public alike have been acutely aware of the potential ... people might still recall the pandemics of 1968 and 1957, ... recurrence on that scale--that causes the most trepidation. ... people died from this particular strain of the flu virus ...
    Cached Biology News:Study offers window into human behavior, brain disease 2Study offers window into human behavior, brain disease 3Study offers window into human behavior, brain disease 4Honey bee genome holds clues to social behavior 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3
    Request Info...
    Automated -80° C sample library for microplates and cryotube racks in SBS format; for integration into automated processes....
    Automated -80° C sample library for microplates and cryotube racks in SBS format; for integration into automated processes....
    Automated centrifuge for the processing of microplates and tubes; can be integrated into automated process using inexpensive robotics due to its unique sample handling platform....
    Biology Products: